Douglas Phillips

Senior Scientist, Antibody Discovery at Mabylon

Speaker

As Senior Scientist, Antibody Discovery at Mabylon AG in Zurich, Doug Phillips focuses on the discovery of novel human-derived antibody therapeutics to address several unmet medical needs in the treatment of allergies and neurological disorders. He received his PhD in antibody discovery from the University of Reading and has developed extensive experience in the discovery and engineering of antibodies, alternative scaffolds and scFvs for use as therapeutics.